Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

More Na+/H+-exchange inhibitors from E. Merck

June 14, 1996

Na+/H+-exchange inhibitors from Sumitomo

June 14, 1996

Cardiovascular disorders treatment from Boryung Pharm.

June 14, 1996

Merck & Co. discloses endothelin antagonists

June 14, 1996

Endothelin antagonists from Abbott

June 14, 1996

Tranilast: An angiotensin II antagonist

June 7, 1996

Cytel's cell adhesion inhibitor trial discontinued

June 7, 1996

First chronotherapeutic agent for hypertension and angina now avaliable in U.S.

June 7, 1996

Warner-Lambert reveals indole endothelin antagonists

June 7, 1996

Taisho researchers reveal cGMP-dependent phosphodiesterase (PDE V) inhibitors

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...